Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock: Difference between revisions
Jump to navigation
Jump to search
TOstryzniuk (talk | contribs) (added) |
TOstryzniuk (talk | contribs) mNo edit summary |
||
| Line 4: | Line 4: | ||
| Primary Author = Zelenitskya Sheryl | | Primary Author = Zelenitskya Sheryl | ||
| Other Authors = Rubinsteinc Ethan, Arianoa Robert, Iacovidesa Harris, Dodekd Peter, | | Other Authors = Rubinsteinc Ethan, Arianoa Robert, Iacovidesa Harris, Dodekd Peter, | ||
Mirzanejade Yazdan, Anand | Mirzanejade Yazdan, Kumar Anand , the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) | ||
Database Research Group | Database Research Group | ||
| PubType = Publication | | PubType = Publication | ||
Revision as of 16:03, 2018 June 21
| Publication | |
| Publication: | Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock |
| Year: | 2012 |
| Authors: | Zelenitskya Sheryl, Rubinsteinc Ethan, Arianoa Robert, Iacovidesa Harris, Dodekd Peter,
Mirzanejade Yazdan, Kumar Anand , the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group |
| Publication Type: | Publication |
| Journal: | International Journal of Antimicrobial Agents |
| DOI: | http://dx.doi.org/10.1016/j.ijantimicag.2012.10.015 |
| Program: | Critical Care |
| Through MCHP: | no |